PROPARACAINE Drug Patent Profile
✉ Email this page to a colleague
When do Proparacaine patents expire, and what generic alternatives are available?
Proparacaine is a drug marketed by Bausch And Lomb Inc, Mankind Pharma, Micro Labs, Rising, Sola Barnes Hind, and Somerset Theraps Llc. and is included in seven NDAs.
The generic ingredient in PROPARACAINE is proparacaine hydrochloride. There is one drug master file entry for this compound. Ten suppliers are listed for this compound. Additional details are available on the proparacaine hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Proparacaine
A generic version of PROPARACAINE was approved as proparacaine hydrochloride by BAUSCH AND LOMB INC on September 29th, 1995.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for PROPARACAINE?
- What are the global sales for PROPARACAINE?
- What is Average Wholesale Price for PROPARACAINE?
Summary for PROPARACAINE
| US Patents: | 0 |
| Applicants: | 6 |
| NDAs: | 7 |
| Drug Prices: | Drug price information for PROPARACAINE |
| DailyMed Link: | PROPARACAINE at DailyMed |


